Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo.

Borgström, P; Bourdon, M A; Hillan, K J; Sriramarao, P; Ferrara, N

Borgström, P; Bourdon, M A; Hillan, K J; Sriramarao, P; Ferrara, N.

Affiliation

Borgström P; Sidney Kimmel Cancer Center, San Diego, California 92121, USA.

Prostate ; 35(1): 1-10, 1998 Apr 01.

Article in En | MEDLINE | ID: mdl-9537593

Subject(s)

Antibodies, Monoclonal/pharmacology; Endothelial Growth Factors/antagonists & inhibitors; Lymphokines/antagonists & inhibitors; Neovascularization, Pathologic/prevention & control; Prostatic Neoplasms/blood supply; Prostatic Neoplasms/pathology; Animals; Antibodies, Monoclonal/therapeutic use; Endothelial Growth Factors/immunology; Fluorescent Dyes; Humans; Lymphokines/immunology; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasm Transplantation; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Endothelial Growth Factors / Lymphokines / Antibodies, Monoclonal / Neovascularization, Pathologic Limits: Animals / Humans / Male Language: En Journal: Prostate Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links